Human CGRP receptor binding proteins
US12122841B2 · kind B2 · utility
0Cited by
14References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 3, 2020 |
| Grant date | Oct 22, 2024 |
| Priority date | — |
| Expiry date | Nov 26, 2042 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/53
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Antigen binding proteins that bind to human CGRP receptor (CGRP R) are provided. Nucleic acids encoding the antigen binding protein, vectors, and cells encoding the same are also provided. The antigen binding proteins can inhibit binding of CGRP R to CGRP, and are useful in a number of CGRP R related disorders, including the treatment and/or prevention of migraine headaches.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.